Ceapro — Investor Presentation (April 2016)
31 slides from Ceapro's investor presentation, April 2016
Slide 1: Enhancing Life Through Nature – Corporate Presentation
Enhancing Life Through Nature Corporate Presentation TSX: CZO April 2016 www.ceapro.com
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements, including those predicting the timing of product development and launches. Although the company believ
Slide 3: Corporate Overview
Corporate Overview Focused on the development and commercialization of active ingredients for healthcare and cosmetic industries - Unrivaled, proprietary plant extraction based manufacturing process Two active ingredients currently used in multiple household name products – cosmetics & personal care
Slide 4: Core Expertise
Core Expertise Identification, extraction and purification of active compounds from natural sources Create innovative ingredients for the personal and healthcare industries 4
Slide 5: From Field to Formulation
From Field to Formulation Field Research Manufacturing Consumer Identify Discover Develop Provide Novel Unique Functional Innovative Innovative Plants Actives Processes Products 5
Slide 6: Unique Bioprocessing Expertise
Unique Bioprocessing Expertise Ability to isolate and purify specific molecules from a wide range of botanical sources Prototype extracts are then prepared for bio-screening or in vivo testing Unique drying (heat-free) technology for sensitive compounds Commercialized unique bio-actives from several
Slide 7: New & Innovative Technologies
New & Innovative Technologies Pressurized Gas Expanded (PGX) Technology 7
Slide 8: Proprietary Plant Extraction Based Manufacturing: Lead Active Ingredients
Proprietary Plant Extraction Based Manufacturing Lead Active Ingredients Beta Glucan Avenanthramides Lupinus angustifolia and Avena sativa 8
Slide 9: Beta Glucan and Avenanthramides in Multiple Household Name Products
Beta Glucan and Avenanthramides in Multiple Household Name Products Aveeno Coppertone Jergens Dove Lubriderm Burt’s Bees 3M – Nexcare The Body Shop KY Products Philosophy Neutrogena ROC 9
Slide 10: Financial Performance 2012-2015
Financial Performance 2012-2015 12 10 8 6 4 2 0 2012 2013 2014 2015 -2 Revenue, ($M) Income (loss) from operations, $000000 10
Slide 11: Opportunity to Expand into Multiple Markets
Opportunity to Expand into Multiple Markets Cosmeceuticals Nutraceuticals Pharmaceuticals 11
Slide 12: Fueling Our Pipeline
Fueling Our Pipeline Pre-Clinical Clinical Market Beta Glucan Cosmetics and Personal Care Functional Drink Cholesterol Avenanthramides Cosmetics and Personal Care Exercised Induced Inflammation 12
Slide 13: Beta Glucan
Beta Glucan Beta glucan is a water soluble fibre found in the cell walls of oat kernels Acts as a natural moisture barrier and film-forming agent Relieves and alleviates dry and itchy skin by replenishing and protecting the skin’s moisture barrier Provides hydration against the drying effects of the
Slide 14: Beta Glucan in Cosmeceuticals
Beta Glucan in Cosmeceuticals Ceapro was the first to demonstrate that high molecular weight beta glucan can penetrate human skin Dermatology applications range from anti-ageing to wound healing New highly purified beta glucan powder successfully developed to address new market demands/trends 14
Slide 15: Natural Skin Restructuring Agent
Natural Skin Restructuring Agent Proven to effectively reduces fine lines & wrinkles Forms a natural barrier protecting skin Wound healing agent – films or gels Sustained release of active agents requiring enhanced percutaneous transportation 15
Slide 16: Beta Glucan in Nutraceuticals and Pharmaceuticals
Beta Glucan in Nutraceuticals and Pharmaceuticals Potential reduction of cardiovascular and heart diseases risk - Acts to decrease LDL and total cholesterol Proprietary beta glucan drug-delivery platform - Shown to effectively penetrate into the skin, into the deep layers as well as into the skin ce
Slide 17: Unique Enabling Technology - PGX
Unique Enabling Technology - PGX Pressurized Gas Expanded (PGX) Liquid – Spray Drying PGX is a novel spray drying technique for processing water-soluble biopolymers - Platform that can produce numerous morphologies of biopolymers ranging from fine fibres to granular powder, which are highly water so
Slide 18: PGX-BG Impregnated with CoQ10 (iBG)
PGX-BG Impregnated with CoQ10 (iBG) Impregnation of highly porous biopolymer matrix - with thermosensitive bioactives (or drugs, API) - Nutraceuticals - Functional food ingredients Pure PGX BG - Drug Delivery Vehicle Impregnation is accomplished - by means of supercritical CO2 - in the same processi
Slide 19: CNC Before and After PGX Drying
CNC Before and After PGX Drying Production of biomaterials from different industries 0.5 g CNC 0.5 g CNC Spray Dried PGX Dried CNC AEROGEL Density : 0.006 g/cm3 19
Slide 20: Impregnation of PGX-GA with b-Carotene
Impregnation of PGX-GA with b-Carotene 20
Slide 21: PGX - A New Platform Technology
PGX - A New Platform Technology Application of PGX-CNC - Wound healing, scaffolds - Drug delivery - Absorbents - Composite-plastic - Paints PGX processing allows processing of high value biopolymers - Beta Glucan - Chitosan - Gum Arabic - CNC 21
Slide 22: Avenanthramides
Avenanthramides Antihistamine and anti-inflammatory properties Potential benefits in the control of inflammation-based diseases 22
Slide 23: Avenanthramides Clinically Proven in Cosmeceuticals
Avenanthramides Clinically Proven in Cosmeceuticals Significant improvements in erythema symptoms associated in subjects with mild to moderate atopic dermatitis - 40% improvement in itch perception after 1 week - 62% of patients showed an improvement in their skin condition Subjects with atopy - 89%
Slide 24: Advanced Skin Care
Advanced Skin Care Skin inflammation is a complex physiological process Beta Glucan Beta glucan - Accelerates tissue healing - Deep hydrating agent - Improves elasticity - Natural film protective barrier Avenanthramides - Relief from itching (Pruritus) - Reduces inflammation and swelling - Reduces r
Slide 25: Avenanthramides in Nutraceuticals and Pharmaceuticals
Avenanthramides in Nutraceuticals and Pharmaceuticals Avenanthramides shown to attenuate exercise-induced inflammation in animal studies Human clinical studies showed that dietary avenanthramides supplements significantly reduced inflammation biomarkers in both elderly and young population New proce
Slide 26: Strategy Designed to Leverage Enabling Technologies
Strategy Designed to Leverage Enabling Technologies • Generate scientific data to support current product indications • Pursue new indications for current product portfolio from research programs • Develop new products in accordance with needs expressed by customers Cosmeceuticals • Improve manufact
Slide 27: Value Drivers
Value Drivers Cosmeceuticals - Current and new indications - Base business Nutraceuticals - New product development - Near term catalyst Pharmaceuticals - New products, new partnership discussions Manufacturing Innovation - New processes, higher output, lower cost 27
Slide 28: New Bio-Processing Facility
New Bio-Processing Facility R&D Pilot Scale Capability Commercial Production New 30,000 sq. ft. GMP Bio-processing Extraction Facility in Edmonton, Alberta, Canada 28
Slide 29: Financial Profile
Financial Profile Highest revenues, profits and cash flows reported in Company’s history for FY 2015 TSX-V: CZO Stock Ticker $43.8M Market capitalization as of April 20, 2016 62.6M Common shares outstanding $10,667,000 Total sales for the full year 2015 $5,000,000 Total amount of grant-based-funding
Slide 30: Value-Driving Milestones
Value-Driving Milestones Q1 2016 Q2 2016 Q3 2016 Q4 2016 Complete New Manufacturing Facility Complete Commercial Scale-up of PGX PGX Alliance Opportunities Nutraceuticals and Pharmaceuticals Beta Glucan: Conduct Safety Studies of High Purity Beta Glucan in Oral Formulation Beta Glucan: Commence Chol
Slide 31: Enhancing Life Through Nature
Enhancing Life Through Nature Corporate Presentation TSX: CZO www.ceapro.com